middle.news
How Integral Diagnostics Exceeded FY25 Targets with Capitol Merger Synergies
11:26pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
How Integral Diagnostics Exceeded FY25 Targets with Capitol Merger Synergies
11:26pm on Friday 29th of August, 2025 AEST
Key Points
33.7% revenue growth to AUD 628.0 million
Operating EBITDA up 38.3% with margin expansion to 20.1%
Annualised merger synergies exceed expectations at AUD 14.0 million
Operating NPAT rises 74.4% to AUD 31.6 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Integral Diagnostics (ASX:IDX)
OPEN ARTICLE